Prostate Cancer
HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES.
August 23, 2024
Precision Drug Olaparib May Be Effective Without Hormone Therapy for Some Men with Biochemically Recurrent Prostate Cancer
August 22, 2024
Radiotherapy and immunology
August 22, 2024
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.
August 22, 2024
Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake.
August 22, 2024
PSMA-Targeted 2-Deoxyglucose-Based Dendrimer Nanomedicine for the Treatment of Prostate Cancer.
August 22, 2024
Epigenome-wide association study of prostate cancer in African American men identified differentially methylated genes.
August 22, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.
August 21, 2024
Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial).
August 21, 2024